These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [2 cases of kidney damage during the treatment with gold preparations]. Wanic-Kossowska M; Turczak-Bierła I; Grzegorzewska A Przegl Lek; 1990; 47(11):788-90. PubMed ID: 2129137 [No Abstract] [Full Text] [Related]
7. Mucocutaneous toxicity of gold salts by parenteral administration--rechallenge with auranofin. Tumiati B; Veneziani M; Bellelli A; Portioli I J Rheumatol; 1987 Feb; 14(1):177. PubMed ID: 2952794 [No Abstract] [Full Text] [Related]
8. [Oral lichenoid reaction secondary to gold salt therapy]. Vallejo Irastorza G; López Cedrún JL; Marínez-Conde R; Aguirre Urízar JM Av Odontoestomatol; 1990 Feb; 6(2):131-3. PubMed ID: 2118353 [TBL] [Abstract][Full Text] [Related]
9. Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate. Bax DE; Amos RS Ann Rheum Dis; 1985 Mar; 44(3):194-8. PubMed ID: 2858182 [TBL] [Abstract][Full Text] [Related]
10. [Effect of gold therapy on proteins and glycoproteins in patients with rheumatoid arthritis]. Bernacka K Reumatologia; 1966; 4(2):187-93. PubMed ID: 5955852 [No Abstract] [Full Text] [Related]
11. [Selective and generalized hypogammaglobulinemia in patients with rheumatoid arthritis in treatment with gold salts]. Bambara LM; Biasi D; Caramaschi P; Codella O; De Sandre G Ann Ital Med Int; 1986 Dec; 1(4):298-302. PubMed ID: 3275190 [No Abstract] [Full Text] [Related]
12. Hypogammaglobulinaemia associated with gold therapy. So AK; Peskett SA; Webster AD Ann Rheum Dis; 1984 Aug; 43(4):581-2. PubMed ID: 6476915 [TBL] [Abstract][Full Text] [Related]
13. [Morphology and pathogenesis of glomerular renal lesions in gold nephropathy]. Waldmann G; Henzgen S Zentralbl Allg Pathol; 1983; 128(1-2):41-52. PubMed ID: 6415954 [TBL] [Abstract][Full Text] [Related]
14. Low incidence of proteinuria in RA after gold thiosulfate treatment. Salvarini C; Macchioni P; Zizzi F; Rossi F; Baricchi R; Mantovani W; Ghirelli L; Capozzoli N; Frizziero L; Portioli I J Rheumatol; 1990 Feb; 17(2):271-2. PubMed ID: 2108247 [No Abstract] [Full Text] [Related]
15. Gold induced enterocolitis: case report and a review of the literature. Eaves R; Hansky J; Wallis P Aust N Z J Med; 1982 Dec; 12(6):617-20. PubMed ID: 6819847 [TBL] [Abstract][Full Text] [Related]
16. Serum IgA levels and ANA behaviour in rheumatoid patients with and without toxicity to remission-inducing drugs. Ferraccioli GF; Nervetti A; Mercadanti M; Cavalieri F Clin Exp Rheumatol; 1986; 4(3):217-20. PubMed ID: 2945684 [TBL] [Abstract][Full Text] [Related]
17. Toxicity due to remission inducing drugs in rheumatoid arthritis. Association with HLA-B35 and Cw4 antigens. Ferraccioli G; Peri F; Nervetti A; Ambanelli U; Savi M J Rheumatol; 1986 Feb; 13(1):65-8. PubMed ID: 3084782 [TBL] [Abstract][Full Text] [Related]
18. [Treatment with gold salts and systemic erythematosus]. Strejcek J Cas Lek Cesk; 1983 Apr; 122(15):469-72. PubMed ID: 6407754 [No Abstract] [Full Text] [Related]
19. [Sodium gold thiosulfate therapy: an open, viewed, multicenter trial in rheumatoid arthritis patients followed for two years]. Ciompi ML; Amoresano C; Balzarini P; Bazzichi LM; Broggini M; Buratti L; Calcagnile F; Ciocci A; Ferri S; Fichera C; Fumagalli M; Muratore M; Nitti F; Peruz G; Romagnoni G Reumatismo; 2002; 54(3):251-6. PubMed ID: 12404034 [TBL] [Abstract][Full Text] [Related]
20. [Chrysotherapy in rheumatoid polyarthritis]. Suţeanu S; Moangă M Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(2):107-12. PubMed ID: 6139855 [No Abstract] [Full Text] [Related] [Next] [New Search]